Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FNQ3Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,760
Award facts
- Contract value 100% obligated
- $18,760.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,760.21 to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injections on December 18, 2025, with an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies a comprehensive range of pharmaceutical products to support military and veteran healthcare systems. This delivery order for Zepbound, a GLP-1 receptor agonist medication, falls within the company's extensive portfolio of specialty medications and medical supplies delivered through the DLA Medical Supply Chain. The transaction demonstrates AmerisourceBergen's continued capability to fulfill federal pharmaceutical procurement requirements across multiple therapeutic domains, leveraging its comprehensive prime vendor contract vehicle to serve the Defense Health Agency and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DR26FNQ3Y?
SPE2DR26FNQ3Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FNQ3Y worth?
The government has obligated $18,760 on SPE2DR26FNQ3Y.
Is contract SPE2DR26FNQ3Y an order under another contract?
Yes. SPE2DR26FNQ3Y is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNQ3Y competed?
The extent of competition for SPE2DR26FNQ3Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award